| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |